Medicine

UK scientists develop safer foot-and-mouth vaccine

UK scientists develop safer foot-and-mouth vaccine

Published 28/03/2013

LONDON (Reuters) - British scientists have developed a new vaccine against foot-and-mouth disease that is safer and easier to manufacture, an advance they believe should [more…]

Pfizer gets new rebuff from UK cost body for cancer drug

Pfizer gets new rebuff from UK cost body for cancer drug

Published 28/03/2013

LONDON (Reuters) - Pfizer suffered a second rejection in two days from Britain's health cost watchdog NICE as its new kidney cancer drug Inlyta was [more…]

FDA approves Biogen’s oral MS drug, Tecfidera

FDA approves Biogen’s oral MS drug, Tecfidera

Published 27/03/2013

WASHINGTON (Reuters) - U.S. regulators on Wednesday approved a new multiple sclerosis drug made by Biogen Idec Inc that is widely expected to become the [more…]

China’s “black clinics” flourish as government debates health reform

China’s “black clinics” flourish as government debates health reform

Published 27/03/2013

BEIJING (Reuters) - A one-room shack with a single, bare light bulb on a non-descript Beijing side street is 29-year-old Chinese migrant worker Zhang Xuefang's [more…]

Little hope seen for millions priced out of health overhaul

Little hope seen for millions priced out of health overhaul

Published 26/03/2013

MIAMI (Reuters) - Millions of Americans will be priced out of health insurance under President Barack Obama's healthcare overhaul because of a glitch in the [more…]

Michigan official seeks grand jury to probe meningitis outbreak

Michigan official seeks grand jury to probe meningitis outbreak

Published 26/03/2013

LANSING, Mich (Reuters) - Michigan's attorney general on Tuesday asked state courts to authorize a grand jury to investigate whether a company linked to a [more…]

Pfizer’s drug to treat tuberculosis in short supply

Pfizer’s drug to treat tuberculosis in short supply

Published 25/03/2013

(Reuters) - The Food and Drug Administration has added Pfizer Inc's tuberculosis treatment rifampin to its list of drugs in short supply, the latest in [more…]

FDA rejects United Therapeutics’ oral hypertension drug again

FDA rejects United Therapeutics’ oral hypertension drug again

Published 25/03/2013

(Reuters) - Biotechnology company United Therapeutics Corp said the oral version of its drug to treat hypertension was rejected for the second time by health [more…]

FDA delays approval of GSK bird flu vaccine

FDA delays approval of GSK bird flu vaccine

Published 25/03/2013

LONDON (Reuters) - Regulators have delayed approval of an H5N1 bird flu vaccine from GlaxoSmithKline, designed to be used in a pandemic. A spokesman for [more…]

Analysis: Roche stays a step ahead of copycat drugmakers

Analysis: Roche stays a step ahead of copycat drugmakers

Published 25/03/2013

ZURICH (Reuters) - Delays in developing copies of Roche's top-selling biotech drug are justifying the Swiss company's decision to stay out of biotech generics to [more…]